India Gets Wegovated—Novo’s Star Slimming Shot Makes Its Move

Novo Nordisk India is set for the long-awaited release of its best-selling anti-obesity drug Wegovy (semaglutide), with distribution already on the ground within the country. The move is a milestone in the obesity treatment history of India, with the country having among the world's highest obesity burdens.

 

1. Strategic Rollout and Market Potential

2. Product Details and Accessibility

3. Competitive Landscape and Regulatory Support

Sources: Economic Times, Business Today, Business Standard